Entera Bio Ltd. raises $275.0M (United States, Aug 2026)
Find the investors funding Health rounds
326,000+ verified VCs, angels and family offices — direct emails, check sizes and stage filters.
ENTX: $275M financing in July 2026 secures funding for pivotal Phase 3 trial and extends cash runway to 2030 - TradingView
Entera Bio Ltd. is a biotechnology company focused on developing oral drug delivery systems for biologics. The company aims to improve patient compliance and expand the market for biologic therapies. The recent financing will support a pivotal Phase 3 trial for its lead product, EB613.
ENTX: $275M financing in July 2026 secures funding for pivotal Phase 3 trial and extends cash runway to 2030 TradingView
20,207 investors back startups in United States
You just read who funded Entera Bio Ltd.. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 5 investor contact unlocks a month, no card required.